Regulation of B-cell development and tolerance by different members of the miR-17∼1/492 family microRNAs

Nature Communications

Volumn 7, Issue , 2016, Pages

  Lai, Maoyi ^a   Gonzalez Martin, Alicia ^a   Cooper, Anthony B ^a   Oda, Hiroyo ^a   Jin, Hyun Yong ^a   Shepherd, Jovan ^a   He, Linling ^a   Zhu, Jiang ^a   Nemazee, David ^a   Xiao, Changchun ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 17 92; MICRORNA 19; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG; MIRN17 MICRORNA, MOUSE; MIRN17-92 MICRORNA, MOUSE; MIRN19 MICRORNA, MOUSE; PTEN PROTEIN, MOUSE;

CELLS AND CELL COMPONENTS; CLUSTER ANALYSIS; DEVELOPMENTAL STAGE; GENE EXPRESSION; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; FEMALE; FEMUR; HEMATOPOIETIC STEM CELL; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; LYMPH NODE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPLEEN; TIBIA; ANIMAL; ANIMAL MODEL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRORNAS; MODELS, ANIMAL; PTEN PHOSPHOHYDROLASE;

EID: 84982671396     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms12207     Document Type: Article

References (56)

1. Rajewsky, K. Clonal selection and learning in the antibody system. Nature 381, 751-758 (1996).
2. Goodnow, C. C., Sprent, J., Fazekas de St Groth, B. & Vinuesa, C. G. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435, 590-597 (2005).
3. Nemazee, D. Receptor editing in lymphocyte development and central tolerance. Nat. Rev. Immunol. 6, 728-740 (2006).
4. Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374-1377 (2003).
5. Ambros, V. The functions of animal microRNAs. Nature 431, 350-355 (2004).
6. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
7. Bushati, N. & Cohen, S. M. microRNA functions. Annu. Rev. Cell Dev. Biol. 23, 175-205 (2007).
8. Bartel, D. P. MicroRNAs: Target recognition and regulatory functions. Cell 136, 215-233 (2009).
9. Altuvia, Y. et al. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. 33, 2697-2706 (2005).
10. Griffiths-Jones, S., Saini, H. K., van Dongen, S. & Enright, A. J. miRBase: Tools for microRNA genomics. Nucleic Acids Res. 36, D154-D158 (2008).
11. Saini, H. K., Griffiths-Jones, S. & Enright, A. J. Genomic analysis of human microRNA transcripts. Proc. Natl Acad. Sci. USA 104, 17719-17724 (2007).
12. Baskerville, S. & Bartel, D. P. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11, 241-247 (2005).
13. Kuchen, S. et al. Regulation of microRNA expression and abundance during lymphopoiesis. Immunity 32, 828-839 (2010).
14. Kim, Y. K. et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res. 37, 1672-1681 (2009).
15. Sass, S. et al. MicroRNAs coordinately regulate protein complexes. BMC Syst. Biol. 5, 136 (2011).
16. Mendell, J. T. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133, 217-222 (2008).
17. Tanzer, A. & Stadler, P. F. Molecular evolution of a microRNA cluster. J. Mol. Biol. 339, 327-335 (2004).
18. Spierings, D. C. et al. Ordered progression of stage-specific miRNA profiles in the mouse B2 B-cell lineage. Blood 117, 5340-5349 (2011).
19. Ventura, A. et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132, 875-886 (2008).
20. Dai, R. et al. Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS ONE 5, e14302 (2010).
21. Lindberg, R. L., Hoffmann, F., Mehling, M., Kuhle, J. & Kappos, L. Altered expression of miR-17-5p in CD4 lymphocytes of relapsing-remitting multiple sclerosis patients. Eur. J. Immunol. 40, 888-898 (2010).
22. Qin, H. H. et al. The expression and significance of miR-17-92 cluster miRs in CD4 T cells from patients with systemic lupus erythematosus. Clin. Exp. Rheumatol. 31, 472-473 (2013).
23. Simpson, L. J. et al. A microRNA upregulated in asthma airway T cells promotes TH2 cytokine production. Nat. Immunol. 15, 1162-1170 (2014).
24. Xiao, C. et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 9, 405-414 (2008).
25. Jin, H. Y. et al. MicroRNA-17B92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways. EMBO J. 32, 2377-2391 2013
26. Duong, B. H. et al. Negative selection by IgM superantigen defines a B cell central tolerance compartment and reveals mutations allowing escape. J. Immunol. 187, 5596-5605 (2011).
27. Hardy, R. R. & Hayakawa, K. Development of B cells producing natural autoantibodies to thymocytes and senescent erythrocytes. Springer Semin. Immunopathol. 26, 363-375 (2005).
28. Wang, H. & Clarke, S. H. Positive selection focuses the VH12 B-cell repertoire towards a single B1 specificity with survival function. Immunol. Rev. 197, 51-59 (2004).
29. Goodnow, C. C. Transgenic mice and analysis of B-cell tolerance. Annu. Rev. Immunol. 10, 489-518 (1992).
30. Hartley, S. B. et al. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353, 765-769 (1991).
31. Srinivasan, L. et al. PI3 kinase signals BCR-dependent mature B cell survival. Cell 139, 573-586 (2009).
32. Hartley, S. B. et al. Elimination of self-reactive B lymphocytes proceeds in two stages: Arrested development and cell death. Cell 72, 325-335 (1993).
33. Lang, J. et al. Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J. Exp. Med. 186, 1513-1522 (1997).
34. Shan, S. W. et al. MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat. Cell Biol. 11, 1031-1038 (2009).
35. Hobeika, E. et al. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl Acad. Sci. USA 103, 13789-13794 (2006).
36. Ramadani, F. et al. The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development. Sci. Signal. 3, ra60 (2010).
37. Koralov, S. B. et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132, 860-874 (2008).
38. Strasser, A., Harris, A. W., Bath, M. L. & Cory, S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348, 331-333 (1990).
39. Marsden, V. S. & Strasser, A. Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu. Rev. Immunol. 21, 71-105 (2003).
40. Mavrakis, K. J. et al. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat. Cell Biol. 12, 372-379 (2010).
41. Mu, P. et al. Genetic dissection of the miR-17B92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 23, 2806-2811 (2009).
42. Olive, V. et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 23, 2839-2849 (2009).
43. Olive, V. et al. A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis. Elife 2, e00822 (2013).
44. Li, Y. et al. The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice. Blood 119, 4486-4498 (2012).
45. Lesche, R. et al. Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis 32, 148-149 (2002).
46. Rickert, R. C., Roes, J. & Rajewsky, K. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25, 1317-1318 (1997).
47. Mostoslavsky, G. et al. Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation. Mol. Ther. 11, 932-940 (2005).
48. Nojima, T. et al. In-vitro derived germinal centre B cells differentially generate memory B or plasma cells in vivo. Nat. Commun. 2, 465 (2011).
49. He, L. et al. Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcoding. Sci. Rep. 4, 6778 (2014).
50. Tiller, T., Busse, C. E. & Wardemann, H. Cloning and expression of murine Ig genes from single B cells. J. Immunol. Methods 350, 183-193 (2009).
51. Wu, X. et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333, 1593-1602 (2011).
52. Zhou, T. et al. Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies. Immunity 39, 245-258 (2013).
53. Zhu, J. et al. Somatic populations of PGT135-137 HIV-1-neutralizing antibodies identified by 454 pyrosequencing and bioinformatics. Front. Microbiol. 3, 315 (2012).
54. Zhu, J. et al. Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains. Proc. Natl Acad. Sci. USA 110, 6470-6475 (2013).
55. Zhu, J. et al. De novo identification of VRC01 class HIV-1-neutralizing antibodies by next-generation sequencing of B-cell transcripts. Proc. Natl Acad. Sci. USA 110, E4088-E4097 (2013).
56. Larkin, M. A. et al. Clustal W and Clustal X version 2. 0. Bioinformatics 23, 2947-2948 (2007).